Sanjay N Rao MD

Cataract Related, Cornea & External Disease, Refractive Surgery

Director, Advanced Anterior Segment Surgery

6201 W 95th StOak Lawn, IL 60453
Phone+1 708-636-9393
Fax+1 708-636-2022

Dr. Rao is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Rao's full profile Already have an account?

Summary

Dr. Sanjay Rao is a board-certified ophthalmologist and fellowship trained cornea, cataract and LASIK surgery specialist in Orland Park and Oak Lawn, IL. He received his medical degree from The Warren Alpert Medical School of Brown University and has been in practice 21 years. He completed his ophthalmology residency at the prestigious USC/Doheny Eye Institute. He also completed his fellowship in Cornea, Refractive Surgery, and External Disease at Rush University in Chicago, IL. He also speaks multiple languages, including Spanish. He specializes in cataract related, cornea & external disease, and refractive surgery and is experienced in refractive surgery, cataract surgery, corneal transplant surgery, cornea / external disease, and dry eye. He has more than 10 publications and over 450 citings. He also is director of the clinical research program and participates is multiple ongoing clinical trials.

Education & Training

Rush University Medical CenterFellowship, Cornea, External Diseases, and Refractive Surgery, 2000 - 2001
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Ophthalmology, 1997 - 2000
Loyola Medicine MacNeal HospitalInternship, Transitional Year, 1996 - 1997
The Warren Alpert Medical School of Brown UniversityClass of 1996

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 1998 - Present
IL State Medical License 1972 - 2029
WI State Medical License 2001 - 2007
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification MaximEyes SQL Electronic Health Records, First Insight Corporation, 2011, 2013-2014, 2016
CMS Meaningful Use Stage 2 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2011, 2013-2014, 2016
CMS Meaningful Use Stage 2 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2011, 2013-2014, 2016

Clinical Trials

Effect of Intraoperative Dexamethasone on Post-op Dry Eye Start of enrollment: 2019 Aug 10
COMPLETED
PHASE4
Topical Cyclosporine and Disease Progression
COMPLETED
PHASE4

Publications & Presentations

PubMed

3 citations
First Real-World, Multicenter, Post-Marketing, Retrospective Study of Dexamethasone Intraocular Suspension for Inflammation After Cataract Surgery.
Jason Bacharach, Cathleen McCabe, Mitchell Jackson, Sanjay Rao, I Paul Singh
Clinical Ophthalmology. 2022-01-01
23 citations
Reversibility of dry eye deceleration after topical cyclosporine 0.05% withdrawal.
Sanjay N. Rao
Journal of Ocular Pharmacology and Therapeutics. 2011-12-13
62 citations
Topical Cyclosporine 0.05% for the Prevention of Dry Eye Disease Progression
Sanjay N. Rao
Journal of Ocular Pharmacology and Therapeutics. 2010-04-25